<html><body><div class="mB10"><p class="light"><span class="fwB">Multicenter study of organizational culture and efficiency indicators of hospital management.</span><br/></p><p class="light mB10">(International Health Economics Association, 10th World Congress 2014/07/16)</p></div><div class="mB10"><p class="light"><span class="fwB">Organizational culture for efficient hospital management versus patient satisfaction: Multi-institutional, multi-professional analysis.</span><br/></p><p class="light mB10">(International Health Economics Association, 10th World Congress 2014/07/14)</p></div><div class="mB10"><p class="light"><span class="fwB">脳梗塞患者集団における機能別医療・介護資源消費推移の可視化</span><br/></p><p class="light mB10">(第51回日本医療・病院管理学会学術総会 2013/09/27)</p></div><div class="mB10"><p class="light"><span class="fwB">在院日数が短い病院では医療従事者の業務負担感が大きいのか?―多施設大規模質問紙調査とDPCデータの解析―</span><br/></p><p class="light mB10">(第51回日本医療・病院管理学会学術総会 2013/09/27)</p></div><div class="mB10"><p class="light"><span class="fwB">The number of cardiologists, case volume and in-hospital mortality for acute myocardial infarction</span><br/></p><p class="light mB10">(医療経済学会第8回研究大会 2013/09/07)</p></div><div class="mB10"><p class="light"><span class="fwB">Organizational culture and its relationship with hospital management: a multicenter questionnaire survey and administrative data</span><br/></p><p class="light mB10">(医療経済学会第8回研究大会 2013/09/07)</p></div><div class="mB10"><p class="light"><span class="fwB">Patient-oriented costing by function tracing: theoretical development and practical application.</span><br/></p><p class="light mB10">(International Health Economics Association, 9th World Congress 2013/07/08)</p></div><div class="mB10"><p class="light"><span class="fwB">在宅医療が癌患者の終末期医療費に与える影響の検証―京都府の診療報酬明細書データベースを用いた実証研究―</span><br/></p><p class="light mB10">(第50回日本医療・病院管理学会学術総会 2012/10/19)</p></div><div class="mB10"><p class="light"><span class="fwB">Impact of hospital case volume on quality of end-of-life care among cancer patients: a cross-sectional study using claims data</span><br/></p><p class="light mB10">(医療経済学会第7回研究大会 2012/07/21)</p></div><div class="mB10"><p class="light"><span class="fwB">Cost-effectiveness of omalizumab for the treatment of adults with moderate to severe persistent asthma: results from a randomized controlled trial in Japan</span><br/></p><p class="light mB10">(Society for Medical Decision Making, 33rd Annual Meeting 2011/10/24)</p></div><div class="mB10"><p class="light"><span class="fwB">Cost-effectiveness analysis of omalizumab for the treatment of severe asthma: results from a randomized controlled trial in Japan and the value of responder prediction methods</span><br/></p><p class="light mB10">(医療経済学会第6回研究大会 2011/09/19)</p></div><div class="mB10"><p class="light"><span class="fwB">レセプトから見た非小細胞肺癌(NSCLC)の1st line化学療法のレジメンの実施割合</span><br/></p><p class="light mB10">(第51回日本肺癌学会総会 2010/11/03)</p></div><div><p class="light"><span class="fwB">他 多数</span><br/></p><p class="light mB10"></p></div></body></html>